Neuroone Medical Technologies (NMTC) Shares Outstanding (Diluted Average) (2011 - 2026)

Neuroone Medical Technologies (NMTC) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $8.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 64.37% year-over-year to $8.5 million; the trailing twelve-month figure through Mar 2026 stood at $8.5 million (up 64.37% YoY), and the FY2025 full-year result was $40.2 million, up 50.03% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $8.5 million, down from $50.3 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $50.3 million in Q4 2025 and bottomed at $5.2 million in Q1 2025.
• The 5-year median for Shares Outstanding (Diluted Average) is $18.1 million (2023), against an average of $23.7 million.
• Peak annual rise in Shares Outstanding (Diluted Average) reached 77.7% in 2025, while the deepest fall reached 79.31% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $16.2 million in 2022, then jumped by 47.84% to $24.0 million in 2023, then gained by 28.69% to $30.9 million in 2024, then jumped by 62.99% to $50.3 million in 2025, then tumbled by 83.14% to $8.5 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $8.5 million (Q1 2026), $50.3 million (Q4 2025), and $40.2 million (Q3 2025), per Business Quant data.

Peer Comparison